| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Methotrexate | FAERS: 2 | US FAERS | |
| 2 | Norgestrel | FAERS: 2 | US FAERS | |
| 3 | Citalopram | FAERS: 1 | US FAERS | |
| 4 | Citalopram | FAERS: 1 | US FAERS | |
| 5 | Lamotrigine | FAERS: 1 | US FAERS | |
| 6 | Misoprostol | FAERS: 1 | OFFSIDES US FAERS | |
| 7 | NuvaRing | FAERS: 1 | US FAERS | |
| 8 | Paroxetine | FAERS: 1 | US FAERS | |
| 9 | etonogestrel | FAERS: 1 | US FAERS | |
| 10 | Beclomethasone | OFFSIDES | ||
| 11 | Beclomethasone | OFFSIDES | ||
| 12 | Betaxolol | OFFSIDES | ||
| 13 | Cromolyn Sodium | OFFSIDES | ||
| 14 | Cromolyn Sodium | OFFSIDES | ||
| 15 | Nelfinavir | OFFSIDES | ||
| 16 | Nevirapine | OFFSIDES | ||
| 17 | Nitrofurantoin | OFFSIDES | ||
| 18 | Phosphorus | OFFSIDES | ||
| 19 | lamivudine, zidovudine drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.